A study of 256 patients whose dates and patterns of first mode of recurrence after curative
esophagectomy from 1984 to 2004 revealed the recent improvement in survival after the detection of
tumor recurrence. This tendency was evident in lymphatic recurrence, particularly in the cervical area. Lung
metastasis was another mode of recurrence that has shown recent improvement. In this series, 20 patients with
lymph node metastases underwent reoperation for local or regional
tumor control. The addition of systemic
chemotherapy or
chemoradiotherapy was our general rule. The 5-year survival rate after the detection of
tumor recurrence in these 20 patients was 47.4%. Six with lung
metastases in the group of patients whose
esophagectomies were performed in the last 7 years underwent video-assisted pulmonary
tumor resection. Five patients in this group are alive without signs of further recurrence for 92 to 1,437 days. The early detection of recurrent
tumor, vigorous attempts to achieve locoregional control, and the addition of systemic
chemotherapy are all important in achieving better results. We routinely perform conventional cervical and abdominal ultrasonography and computed tomography every 6 months until 6 years after surgery is performed.